Wells Fargo’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Wells Fargo’s Portfolio IBDX Stock Details IBDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.8M	Buy	3,089,226 +273,891	+10%	+$6.9M	0.01%	784
2026 Q1	$71.1M	Sell	2,815,335 -215,927	-7%	-$5.51M	0.01%	765
2025 Q4	$77.4M	Buy	3,031,262 +139,568	+5%	+$3.57M	0.01%	719
2025 Q3	$74.1M	Buy	2,891,694 +216,566	+8%	+$5.5M	0.01%	728
2025 Q2	$67.6M	Buy	2,675,128 +88,362	+3%	+$2.19M	0.01%	723
2025 Q1	$64.6M	Buy	2,586,766 +64,206	+3%	+$1.59M	0.01%	698
2024 Q4	$62M	Buy	2,522,560 +179,925	+8%	+$4.5M	0.01%	724
2024 Q3	$60.2M	Buy	2,342,635 +105,957	+5%	+$2.68M	0.01%	730
2024 Q2	$54.9M	Buy	2,236,678 +1,374,356	+159%	+$33.6M	0.01%	732
2024 Q1	$21.4M	Buy	862,322 +275,074	+47%	+$6.82M	0.01%	1190
2023 Q4	$14.8M	Buy	587,248 +207,631	+55%	+$4.95M	﹤0.01%	1391
2023 Q3	$8.91M	Buy	379,617 +196,763	+108%	+$4.75M	﹤0.01%	1647
2023 Q2	$4.5M	Buy	182,854 +58,661	+47%	+$1.45M	﹤0.01%	2227
2023 Q1	$3.11M	Buy	124,193 +90,914	+273%	+$2.25M	﹤0.01%	2487
2022 Q4	$805K	Buy	+33,279	New	+$799K	﹤0.01%	3367

Other funds holding IBDX

ACA

Aptus Capital Advisors Fairhope, Alabama $14.6B AUM 22.78% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

CAI

Capital Advisors Inc Tulsa, Oklahoma $6.8B AUM 26.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SIC

Sigma Investment Counselors Northville, Michigan $2.05B AUM 18.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Klingman & Associates New York $2.35B AUM 23.18% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo's IBDX Position: Q2 2026 in Review

Wells Fargo increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 9.7% in Q2 2026, buying an estimated $6.9M and bringing the position to 3,089,226 shares worth $77.8M. The position accounts for 0.01% of the portfolio, ranked #784.

Wells Fargo first reported a position in IBDX in Q4 2022 and has held it in 15 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

Wells Fargo held 3,089,226 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $77.8M as of Q2 2026.
Wells Fargo bought 273,891 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $6.9M.
iShares iBonds Dec 2032 Term Corporate ETF made up 0.01% of Wells Fargo's portfolio in Q2 2026, its #784 holding.
Wells Fargo first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2022 and has held it in 15 quarters since.
228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.